Kechow Pharma Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
80
- Latest Deal Type
-
Later Stage VC
- Investors
-
12
Kechow Pharma General Information
Description
Researcher and developer of new anti-cancer drugs. The company focuses on the R&D and production of new anti-cancerous drugs with specialized drug development team from discovery, clinical development to registration, enabling patients providing high-quality oncology drugs to meet clinical needs.
Contact Information
Website
www.kechowpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
- Block M, Floor 3, No. 780 Cailun Road
- Zhangjiang Hi-Tech Park, Pudong New Area
- Shanghai, 201203
- China
+86 021 0000 0000
Kechow Pharma Timeline
Kechow Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 22-Dec-2022 | 00000 | Completed | Clinical Trials - Phase 2 | ||
| 6. Secondary Transaction - Private | 17-Sep-2020 | 00000 | Completed | Clinical Trials - Phase 2 | ||
| 5. Later Stage VC (Series D) | 23-May-2019 | 000.00 | 00000 | Completed | Clinical Trials - Phase 2 | |
| 4. Later Stage VC (Series C) | 24-Oct-2019 | 000.00 | 0000 | Completed | Clinical Trials - Phase 2 | |
| 3. Early Stage VC (Series B) | 20-Jun-2018 | 0000 | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series A) | 15-Jan-2016 | $10M | $15M | 0000 | Completed | Pre-Clinical Trials |
| 1. Seed Round | 14-Jul-2014 | $5M | $5M | Completed | Pre-Clinical Trials |
Kechow Pharma Patents
Kechow Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220259164-A1 | Use of aminothiol compounds as cerebral nerve or heart protective agent | Pending | 13-Jun-2019 | 0000000000 | |
| EP-3984993-A1 | Use of aminothiol compounds as cerebral nerve or heart protective agent | Pending | 13-Jun-2019 | 0000000000 | |
| AU-2020293522-A1 | Use of aminothiol compounds as cerebral nerve or heart protective agent | Pending | 13-Jun-2019 | 0000000000 | |
| CA-3142963-A1 | Use of aminothiol compounds as cerebral nerve or heart protective agent | Pending | 13-Jun-2019 | 0000000000 | |
| AU-2017318087-B2 | Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation | Active | 05-Sep-2016 | A61P39/02 |
Kechow Pharma Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Hongqi Tian | Founder, Chairman & Chief Executive Officer | ||
| Yi Liu | Chief Medical Officer |
Kechow Pharma Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hongqi Tian | Kechow Pharma | Founder, Chairman & Chief Executive Officer | 000 0000 |
| Jacky Chen | YuanBio Venture Capital | Board Member | 000 0000 |
Kechow Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Kechow Pharma Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Suzhou Trust | Venture Capital | Minority | 000 0000 | 000000 0 | |
| M31 Capital (China) | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Shenzhen Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Decheng Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Qiming Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |